These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 6421606

  • 1. Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.
    Kehr W.
    Eur J Pharmacol; 1984 Jan 13; 97(1-2):111-9. PubMed ID: 6421606
    [Abstract] [Full Text] [Related]

  • 2. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
    Wachtel H, Kehr W, Sauer G.
    Life Sci; 1983 Dec 26; 33(26):2583-97. PubMed ID: 6607392
    [Abstract] [Full Text] [Related]

  • 3. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K, Ekman A, Piercey MF, Hoffmann WE, Lum JT, Carlsson A.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep 26; 344(3):263-74. PubMed ID: 1683686
    [Abstract] [Full Text] [Related]

  • 4. Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.
    Kehr W.
    Eur J Pharmacol; 1977 Feb 07; 41(3):261-73. PubMed ID: 837971
    [Abstract] [Full Text] [Related]

  • 5. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
    Clark D, Salah RS, Galloway MP.
    Synapse; 1991 Jul 07; 8(3):169-76. PubMed ID: 1948667
    [Abstract] [Full Text] [Related]

  • 6. Lisuride and transdihydrolisuride: differences in action on central dopaminergic functions in dependence on the location and the state of receptors.
    Krejci I, Schuh J, Prágerová H, Dlabac A.
    Pol J Pharmacol Pharm; 1985 Jul 07; 37(3):263-71. PubMed ID: 4070078
    [Abstract] [Full Text] [Related]

  • 7. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H, Engberg G, Pileblad E.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul 07; 344(1):16-28. PubMed ID: 1663587
    [Abstract] [Full Text] [Related]

  • 8. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH, Rossetti ZL, Meloni M, Frau MI, Gessa GL.
    Eur J Pharmacol; 1983 Aug 05; 91(4):463-8. PubMed ID: 6413231
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Suppressive effects of lisuride on the synthesis, release and metabolism of dopamine in rat brain].
    Azuma H, Iwai K, Sato K, Kikuta M, Liu HJ, Oshino N.
    Nihon Yakurigaku Zasshi; 1982 Nov 05; 80(5):325-39. PubMed ID: 6131854
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats.
    Wachtel H, Dorow R, Sauer G.
    Life Sci; 1984 Oct 29; 35(18):1859-67. PubMed ID: 6492995
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quinpirole--a 5-HT receptor antagonist?
    Ahlenius S, Hillegaart V, Wijkström A.
    Neurosci Lett; 1991 May 13; 126(1):57-9. PubMed ID: 1678151
    [Abstract] [Full Text] [Related]

  • 16. Interaction of haloperidol and gamma-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain.
    Kehr W, Speckenbach W, Zimmermann R.
    J Neural Transm; 1977 May 13; 40(2):129-47. PubMed ID: 323421
    [Abstract] [Full Text] [Related]

  • 17. Agonist--antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation.
    Carlsson A, Kehr W, Lindqvist M.
    J Neural Transm; 1977 May 13; 40(2):99-113. PubMed ID: 323424
    [Abstract] [Full Text] [Related]

  • 18. 3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.
    Kehr W.
    J Neural Transm; 1981 May 13; 50(2-4):165-78. PubMed ID: 7241115
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.